Trial NCT04471519; CTRI/2021/04/032942
Publication Vadrevu KM, Sci Rep, 2022
Primary outcome on the report: Neutralising antibody titres against wild-type virus evaluated by two neutralisation assays; a plaque-reduction neutralisation test (PRNT) and a microneutralisation assay (MNT)

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.